Evaluation of S100A12 protein levels in children with Familial Mediterranean Fever

• Published in: Turkish journal of medical sciences Vol. 51; no. 3; pp. 1396 - 1405
• Main Authors: Türkmenoğlu, Yelda, Güney, Elif, Bezen, Diğdem, irdem, Ahmet, Ertürk, Biray, Dursun, Hasan
• Format: Journal Article
• Language: English
• Published: Turkey The Scientific and Technological Research Council of Turkey 28.06.2021
• Subjects: S100A12; Familial Mediterranean fever; children; inflammation
• ISSN: 1300-0144; 1303-6165
• DOI: 10.3906/sag-2009-187

Familial Mediterranean fever (FMF), the most common autoinflammatory disease in children, is characterized by recurrent febrile episodes. FMF is known to progress with chronic inflammation, particularly during attack periods. This study aimed to investigate the relationship of S100A12, an inflammatory marker, with attacks and inflammatory events in FMF patients. The study included 57 patients diagnosed with FMF, 43 in an attack-free period and 14 in an attack period, and 31 healthy children as the control group. Only white blood cell (WBC) count, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), and S100A12 level were analyzed in the control group. In addition, serum amyloid A (SAA), and fibrinogen levels were measured, and a mutation analysis was performed in the patient group. The results were compared among the attack-free period, acute attack FMF and control groups. The mean age of patients and control group was 10 (2.5 - 18) and 9.5 (2.5 - 16) years, respectively. The CRP (p = 0.001), S100A12 (p = 0.003) and ESR (p= 0.001) values differed significantly between the FMF and control groups. S100A12 level (p = 0.027), WBC count (p = 0.003), CRP level (p = 0.0001), ESR (p = 0.004), and fibrinogen level (p = 0.001) differed significantly between the acute attack and attack-free period groups. SAA level (p = 0.05), ESR (p = 0.001), fibrinogen level (p = 0.001), WBC count (p = 0.001), and S100A12 level (p = 0.027) were higher in M694V homozygous FMF patients than in other FMF patients. Patients with FMF had higher S100A12 levels than the control group, while the mean S100A12 concentration was higher in acute attack period patients than in attack-free period patients. S100A12 level might be an important indicator in the monitoring of chronic inflammation in patients with FMF.